DOD Sites Selected for Phase III COVID-19 Vaccine Trials: Five Medical Treatment Facilities in National Capital Region, San Antonio, and San Diego to Participate
Posted by Press Operations on
As part of the Operation Warp Speed's goal to deliver safe and effective vaccines and therapeutics by January 2021, five DOD locations have been identified to participate in the Phase III trial evaluating the vaccine candidate AZD1222 under development by AstraZeneca.
%5 OFF applied to your enitire order!
Morale Patch Armory
Your Patch Panel